Biggest News Aggregation in the World
📰 Aet News

Page 66 - Aet News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Aet. Real-time updates on events, politics, business and more.

Merck KGaA Puts Up €160M for Drug to Rival DNA Damage Cancer Meds From AstraZeneca, Gilead

A Hengrui drug that interferes with a cancer cell’s DNA damage response is heading to Merck KGaA for €160 million up front and up to €1.4 billion tied to milestones. The deal also gives the German company an option to license a Hengrui antibody drug conjugate.
Merck Kgaa Hengrui Daiichi Sankyo Merck Kga Jiangsu Hengrui Pharmaceuticals Gilead Sciences Merck Kgaa

Novartis Drug From $3.2B Deal Succeeds in Phase 3, 2024 FDA Filing Is Planned

Novartis drug candidate atrasentan met the main goal of a pivotal study in the chronic kidney disease IgA nepropathy. It’s one of two drugs added via the multi-billion dollar acquisition of Chinook Therapeutics; together with a homegrown therapeutic candidate, they give Novartis three different approaches to treat the rare disorder.
Shreeram Aradhye Chinook Therapeutics Therapeutic Tarpeyo Travere Therapeutics Novartis President Chief Medical Officer

Improving Hypertension Care for Underserved Populations with Remote Patient Monitoring

Given the impact that RPM can have in addressing chronic conditions like hypertension, there is a distinct need for more funding to ensure all people have access to proven, digital health interventions. Regulations must be revamped so FQHCs, RHCs and CHCs are able to bill for RPM, much like other hospitals and health centers.
United States Centers For Medicare Medicaid Services Health Centers American Heart Association Journal Medicaid Services Federally Qualified Health Centers

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science